- Indications & Safety
- Devices & Dosing
- Reimbursement & Support
- Practitioner Resources
- Patient Resources
- Important Safety Information
Nutropin therapy is indicated for the treatment of pediatric patients who have short stature or growth failure as a result of:
Nutropin therapy is indicated for the replacement of endogenous GH in adults with GH deficiency, either:
WARNINGS AND PRECAUTIONS
USE IN SPECIFIC POPULATIONS
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
Sebastian, a Nutropin patient, and his mom, Andrea, walk through the steps associated with using the NuSpin device for Nutropin therapy.